Sonali Amin

Sonali Amin is a Senior Consultant at Blue Matter since August 2021, specializing in market opportunity assessments within oncology and rare diseases, working closely with C-Suite leadership and cross-functional stakeholders. Prior experience includes three years at Goldman Sachs, where roles encompassed Equity Research Associate and Equity Research Analyst, focusing on large-cap pharmaceutical and biotech companies in Europe, with expertise in financial modeling and equity research reporting. Earlier, Sonali was a Medical Writer at Sciformix, responsible for creating medical responses and conducting literature searches. Academic qualifications include an M.B.A. in Finance from SVKM's Narsee Monjee Institute of Management Studies and a Bachelor of Pharmacy from Bombay College of Pharmacy.